Remove Electronics Remove Ethics Remove Healthcare Remove Patients
article thumbnail

How do Healthcare AI Developers (and Buyers) Stay Ahead of the Regulatory Curve?

Nixon Gwilt Law

That said, the flurry of regulatory policymaking and legislation, congressional hearings and inquiries, and industry stakeholder organization around the development and deployment of healthcare AI portends major developments in the coming years. HIPAA is the pantheon of healthcare data privacy regulation in the U.S. HIPAA What is it?

article thumbnail

Cyberwarfare: A Healthcare Marketers’ Guide in the Fight for Corporate Reputation

PM360

Traditional approaches to mitigating cyber events—even ones that have been successfully implemented on behalf of other sectors—are falling short of the vulnerabilities being created by criminals in the healthcare field. They’ve disabled health systems’ ability to care for their patients. So how should marketers prepare?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Janssen leads effort to cut waste in digital health devices

pharmaphorum

.” The programme has been set up to develop four devices – an e-paper label, smart wearable sensor, smart pill box, and endo-cutter used in surgical procedures – with funding from the EU’s Horizon Europe programme and support from the Waste Electrical and Electronic Equipment (WEEE) Forum.

Leads 121
article thumbnail

Data-Driven Connections: Linking Rare Disease Patients to Clinical Trials, Experts, and Resources

PM360

Simply put, identifying a disorder and receiving a formal diagnosis is at the root of myriad difficulties—from connecting a patient to a community to generating an appropriate care and treatment plan that ideally goes beyond managing symptoms to connecting a patient to clinical trials.

article thumbnail

The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges

Pharma Marketing Network

With the advent of electronic health records, social media, and other digital sources, pharmaceutical companies now have access to vast amounts of data that can be used to inform their marketing strategies. One of the biggest challenges is ensuring that patient privacy is protected. 8 (2018) 2. 1 (2016) 3.

article thumbnail

The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges

Pharma Marketing Network

With the advent of electronic health records, social media, and other digital sources, pharmaceutical companies now have access to vast amounts of data that can be used to inform their marketing strategies. One of the biggest challenges is ensuring that patient privacy is protected. 8 (2018) 2. 1 (2016) 3.

article thumbnail

Evolution of ePROM: Advancements, Concerns, and the Way Forward

PM360

Patients’ directly reported outcomes in certain rare and chronic diseases are considered reliable for understanding the disease’s natural history, palliative treatments that focus primarily on symptom control, and quality of life. 2 For example, in a study by Scripps, ePROMs positively impacted patients’ quality of life in 61.5%